University of Cambridge

Human brain
#Alzheimer's #Artificial intelligence (AI) #Insilico Medicine #Neurodegenerative disorders #Omics #University of Cambridge

Study finds new therapeutic targets for neurodegenerative disease

AI-driven drug discovery company Insilico Medicine and the University of Cambridge have discovered an approach to identify therapeutic targets for human diseases associated with protein phase separation (PPS). In this study, the researchers combined Insilico’s artificial intelligence (AI)-driven target identification engine PandaOmics with the FuzDrop method… Read More

#Editor's Choice #News

DNA
#Biology #Evonetix #Synthetic biology #Synthetic DNA #University of Cambridge

Desktop DNA synthesis could ‘revolutionise’ engineering biology

The first DNA synthesised using Evonetix’s semiconductor chip technology has been delivered to the Department of Chemical Engineering and Biotechnology at the University of Cambridge. The DNA was delivered to Dr Jenny Molloy, Co-chair of the Engineering Biology Interdisciplinary Research Centre at the University of Cambridge. Read More

#News